OPTIMISE: Optimal precision therapies to customise care in childhood and adolescent cancer

OPTIMISE：最佳精准疗法，定制儿童和青少年癌症护理

• 批准号: 465500
• 负责人: Morgenstern Daniel A
• 金额: $ 39.75万
• 依托单位: Hospital for Sick Children (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-03-01 至 2023-08-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=465500&lang=en
• 关键词: Early Phase Clinical Trials; Paediatric Oncology; Precision Medicine; Targeted Therapy

Childhood cancer while rare is nevertheless responsible for the most disease-related deaths in childhood. For children whose cancers relapse after treatment or for whom those initial treatments are unsuccessful, there are often few treatment options. Over

儿童癌症虽然罕见，但却是儿童时期与疾病相关的死亡最多的原因。对于治疗后癌症复发或初始治疗不成功的儿童，治疗选择通常很少。超过